RED+BLUE STRATEGIES for EXPRESS SCRIPTS INC.

Medicare/Medicaid MMM

Monitoring ongoing Medicare and Medicaid regulations and guidance related to prescription medications, PBMs and related entities. Monitoring potential health-related offsets being considered as part of the end of the year wrap package related to Medicare Part D and Medicaid pharmacy benefits. Issues related regulations that have the potential to the survey of mail order and specialty pharmacies for Medicaid purposes. H.R. 8 - American Taxpayer Relief Act of 2012 - Issues related to Pharmacy Benefit Managers that may have been included in the Sustained Growth Rate title of the legislation.

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 8 (112th)

Health Issues HCR

Implementation of the Health Reform Law with a focus on regulations related to the medical loss ratio (MLR), Accountable Care Organizations, Transparency, E-prescribing, Health Information Technology, and Essential Health Benefits. Reauthorization of the Prescription Drug User Fee Act, specifically issues related to track and trace policies and exclusivity. Issues related regulations that have the potential to the survey of mail order and specialty pharmacies for Medicaid purposes. Proposed OPM-focused policies in the Administration's 2013 Budget related to the utilization of Pharmacy Benefit Managers. S. 3187 - The FDA Safety and Innovation Act - Specifically issues regarding down stream supply chain policies and provisions related to the treatment of controlled substances. TriCare and mail order issues. Policies related to stopping prescription medication diversion. H.R. 4310 - National Defense Authorization Act for 2013 - Focused on provisions related to offering mail order options for TriCare beneficiaries. H.R. 8- American Taxpayer Relief Act of 2012 - Focused on issues related to PBMs. Issues related to international naming policies for generic medications

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP)

Bills named: H.R. 8 (112th), H.R. 4310 (112th), S. 3187 (112th)

Pharmacy PHA

H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which creates and antitrust exemption for certain pharmacies. Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Issues impacting PBMs included in the Prescription Drug User Fee Act reauthorization and the Generic Drug User Fee Reauthorization. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Changes in International Naming policies for generic medications.

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1946 (112th)